ARWR
Arrowhead Pharmaceuticals Inc
$66.86
0.00 (0.00%) Today
0.61 (0.92%) Pre-market
— up— down
Market Cap
$9.36B+96.1%
Revenue (TTM)
$657.73M+16.9%
Net Income (TTM)
$-315,568,658
$-315,568,658EPS (TTM)
-2.24
-2.24Shares Out
140.86M
140.86MOpen
$66.25
$66.25Previous Close
$66.25
$66.25Day Range
$64.57 – $66.83
$64.57 – $66.8352-Week Range
$34.38 – $95.49
$34.38 – $95.49Beta
1.32
1.32Earnings Date
Nov 23, 2026
Nov 23, 2026Volume
2.74M
2.74MAvg Volume
2.03M
2.03MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout ARWR
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference (RNAi) mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease.
Related
News
N/AN/AN/A
Arrowhead Pharmaceuticals to Host a Webinar with Interim Clinical Data from a Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies
Yahoo · 22h ago
ARWR Stock: Goldman Sachs Resumes Coverage With $74 Target As Clinical Catalysts Near
Yahoo · 5d ago
Goldman Sachs Reinstates Neutral on Arrowhead Pharma, Announces $74 Price Target
Benzinga · 6d ago